Skip to Main Content

Paper Details

Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
Frontiers in Immunology
1
2021
CD4 Binding Site, CD4 binding site, CD4bs, CD4bs antibody classes, Env, Fc domain, Fv, HIV-1, HIV-1 envelope, MPER, V3, V3-, V3-Glycan Antibodies, VCs, bNAb, bNAbs, clade AE, B and C, gp120, gp120-, gp41, gp41 interface, patients
Author NameAffiliation
Celia C LaBrancheDuke University School of Medicine
Ivelin S GeorgievVanderbilt University Medical Center
David C MontefioriDuke Human Vaccine Institute, Duke University School of Medicine
David C MontefioriDuke University School of Medicine
  • 1 - 4

Datasets

Release 1.2